• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Kahn Swick & Foti

Kahn Swick & Foti represents investors in securities fraud class actions, as well as shareholders and consumers harmed by corporate wrongdoing.

  • About Us
    • About Our Firm
    • Institutional Investor Services
    • KSF in the Community
    • Careers at KSF
    • Contact Us
  • Attorneys
  • Practice Areas
    • Securities Class Action Litigation
    • Corporate Governance And Derivative Litigation
    • Consumer Protection Litigation
    • Shareholder Mergers and Acquisitions Class Action Litigation
    • Antitrust Litigation
  • Current Cases
  • KSF News
  • Client Login
  • Asset Recovery Services
  • Contact KSF

Plaintiffs Win Class Certification in Esperion Therapeutics Securities Litigation

Home»News»Plaintiffs Win Class Certification in Esperion Therapeutics Securities Litigation

On May 31, 2020 the Honorable R. Steven Whalen certified a class of shareholders in Dougherty v. Esperion Therapeutics, Inc. et al, No. 2:16-cv-10089, a securities fraud class action pending in the United States District Court for the Eastern District of Michigan. The allegations of the case involve Defendants’ materially misleading statements and omissions concerning a cardiovascular outcomes trial for the Company’s lead drug candidate. The Court, recommending appointment of KSF as co-class counsel alongside another firm, noted “counsel’s diligent prosecution of this case to date, including a win in the Sixth Circuit,” and highlighted KSF’s “significant collective experience in class litigation.” Judge Whalen recommended a certified Class including: “All persons who purchased or otherwise acquired the common stock of Esperion Therapeutics, Inc. between August 18, 2015 and September 28, 2015 (inclusive) and were damaged thereby.”

Filed Under: News

Previous Post: « Complaint Sustained in Honeywell Securities Class Action Litigation
Next Post: Fitbit Settlement Documents »

Primary Sidebar

Current Cases

Apex Global Brands Inc. (OTC: APEX)

Forterra, Inc. (NasdaqGS: FRTA)

PRA Health Sciences, Inc. (NasdaqGS: PRAH)

Pandion Therapeutics, Inc. (NasdaqGS: PAND)

Boingo Wireless, Inc. (NasdaqGS: WIFI)

Inovio Pharmaceuticals Inc. (NasdaqGS: INO)

see more»
 

Join Our Mailing List

To receive news of interest to shareholders and consumers and learn about potential new cases, you may join our mailing list by entering your email below.

Terms and Conditions | Privacy Notice

© 2006-2021 Copyright. All rights reserved Kahn Swick & Foti LLC · New Orleans · New York — Kahn Swick & Foti LLP · San Francisco